Testing a new blood pressure drug
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must not have high blood pressure caused by another condition (like kidney disease or a hormone problem).
- You must not have a condition called orthostatic hypotension (dizziness or fainting when you stand up).
- You must not need to take other blood pressure drugs during the study.
- You must not have type 1 diabetes or poorly controlled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.
This study tests if a combination drug (sacubitril/valsartan) can help control blood pressure and protect the kidneys in people with both high blood pressure and type 2 diabetes who have early signs of kidney damage.
This study tests an experimental tablet called QR12000 for people with moderate to severe high blood pressure. It aims to see if the treatment is safe and effective. You may join if your blood pressure is not well controlled on your current medicines or if you haven't been treated yet.
This trial tests a medication (sacubitril/allisartan) for people who have both high blood pressure and are overweight or obese. The goal is to see if it helps lower blood pressure and may also help with weight management.
This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.
This trial compares two blood-pressure and heart-failure medicines: sacubitril/valsartan versus ramipril, to see which improves heart pumping and heart structure over time. It’s aimed at people with ischemic (blocked-artery) heart failure with mid-range ejection fraction and ongoing symptoms.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.